Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
BioArctic: Lecanemab Receives Priority Review Status in Japan
BioArctic AB’s partner Eisai has announced that the application for manufacturing and marketing approval for […]
Immusoft Awarded $8M in Funding from the California Institute for Regenerative Medicine (CIRM) for MPS I Clinical Program
Immusoft of CA, a wholly owned subsidiary of Immusoft, a clinical-stage cell therapy company dedicated […]
Legend Biotech Announces CARVYKTI Has Met Primary Endpoint in the Treatment of Relapsed and Refractory Multiple Myeloma
Legend Biotech Corporation, a global biotechnology company developing, manufacturing and commercializing novel therapies to treat […]
Quince Therapeutics Completes the Sale of Legacy Protease Inhibitor Portfolio to Lighthouse Pharmaceuticals
Quince Therapeutics, a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, announced […]
Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication
Ascletis Pharma announces that the China National Medical Products Administration (NMPA) has approved the Investigational […]
New AI Tool Makes Speedy Gene Editing Possible
An artificial intelligence (AI) program may enable the first simple production of customizable proteins called […]
European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer's disease
BioArctic AB‘s partner Eisai have announced that the European Medicines Agency (EMA) has accepted a […]
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome
Syros Pharmaceuticals, a biopharmaceutical company committed to advancing new standards of care for the frontline […]
Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer
Cell BioEngines, a cell and gene therapy company focused on developing an allogenic cell-based product […]
Roche launches COVID-19 PCR Test to Detect the Fast Spreading XBB.1.5 Omicron Sub-variant
Roche and its subsidiary TIB Molbiol have developed a COVID-19 PCR test for researchers that […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more